Wendy Nicholson
Director de Operaciones en Amphista Therapeutics Ltd. .
Cargos activos de Wendy Nicholson
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Teh-Pari International
Teh-Pari International Specialty StoresRetail Trade Teh-Pari International manufactures fragrance and personal care products. It offers perfume oils, incense, candles, henna and accessories. The company was founded by Randy Graves in 1993 and is headquartered in Santa Rosa, CA. | Secretario Corporativo | 08/02/2011 | - |
Amphista Therapeutics Ltd.
Amphista Therapeutics Ltd. BiotechnologyHealth Technology Amphista Therapeutics Ltd. is a biopharmaceutical company based in Biocity Glasgow, UK. The British company is focused on creating first-in-class therapeutics that selectively and efficiently degrade and remove disease-causing proteins using targeted protein degradation (TPD). The company's pipeline of novel small molecules is focused on challenging diseases, including cancer. Amphista is a spin-out of Professor Alessio Ciulli's labs at the University of Dundee and is funded by leading life science investors, including Advent Life Sciences, the European Investment Fund, the Scottish Investment Bank, and Biomotiv. The CEO of the company is Nicola Thompson. | Director de Operaciones | - | - |
Historial de carrera de Wendy Nicholson
Estadísticas
Internacional
Estados Unidos | 2 |
Reino Unido | 2 |
Operativa
Corporate Secretary | 1 |
Chief Operating Officer | 1 |
Sectorial
Retail Trade | 2 |
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Teh-Pari International
Teh-Pari International Specialty StoresRetail Trade Teh-Pari International manufactures fragrance and personal care products. It offers perfume oils, incense, candles, henna and accessories. The company was founded by Randy Graves in 1993 and is headquartered in Santa Rosa, CA. | Retail Trade |
Amphista Therapeutics Ltd.
Amphista Therapeutics Ltd. BiotechnologyHealth Technology Amphista Therapeutics Ltd. is a biopharmaceutical company based in Biocity Glasgow, UK. The British company is focused on creating first-in-class therapeutics that selectively and efficiently degrade and remove disease-causing proteins using targeted protein degradation (TPD). The company's pipeline of novel small molecules is focused on challenging diseases, including cancer. Amphista is a spin-out of Professor Alessio Ciulli's labs at the University of Dundee and is funded by leading life science investors, including Advent Life Sciences, the European Investment Fund, the Scottish Investment Bank, and Biomotiv. The CEO of the company is Nicola Thompson. | Health Technology |
- Bolsa de valores
- Insiders
- Wendy Nicholson
- Experiencia